Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Research Center, |
RCV000625921 | SCV000746507 | likely pathogenic | Corneal dystrophy-perceptive deafness syndrome | 2017-12-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV005056351 | SCV005700714 | uncertain significance | not provided | 2024-10-15 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 704 of the SLC4A11 protein (p.Ala704Thr). This variant is present in population databases (rs748362724, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with SLC4A11-related conditions. ClinVar contains an entry for this variant (Variation ID: 522760). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on SLC4A11 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |